Samsung Biologics ranked among the top searched stocks for 13 days in the past month.

As of 10:30 AM on the 25th, Samsung Biologics is trading at 815,000 KRW, down 0.49% from the previous day. This represents a 33.39% increase compared to May 28. Samsung Biologics is known as the bio business holding company of the Samsung Group.

Today, foreigners have a tentative net purchase of 3,969 shares. Over the past five days, individual investors have net sold 2,327 shares, while foreigners and institutions have net sold 18,930 shares and net bought 26,745 shares, respectively.

On June 24, Samsung Biologics was a market topic for its strong performance following a contract worth 380 billion KRW.



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing